INNOTERE has entered a partnership agreement with TheraVet SA, a vet biotech company headquartered in Belgium, to expand its activities into the field of veterinary medicine. Based on major distribution and research agreements INNOTERE opens his product portfolio to the veterinary market and extends its R&D activities to jointly develop next-generation bone substitutes. More information an be found here.
INNOTERE is looking forward to a great collaboration!